← All MEPs

Clotilde Armand

European Parliament · 🇷🇴 Romania · former MEP

Term: from 18 July 2019 to 23 October 2020

Participation in roll-call votes

95 % of the 215 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % July 2019 : participation 0 % (0 / 1), presence 0 % (0 / 1) 2019 September 2019 : participation 100 % (5 / 5), presence 100 % (5 / 5) October 2019 : participation 95 % (18 / 19), presence 95 % (18 / 19) November 2019 : participation 100 % (18 / 18), presence 100 % (18 / 18) December 2019 : participation 33 % (2 / 6), presence 33 % (2 / 6) January 2020 : participation 83 % (10 / 12), presence 83 % (10 / 12) 2020 February 2020 : participation 100 % (8 / 8), presence 100 % (8 / 8) May 2020 : participation 100 % (54 / 54), presence 100 % (54 / 54) June 2020 : participation 100 % (12 / 12), presence 100 % (12 / 12) July 2020 : participation 100 % (19 / 19), presence 100 % (19 / 19) September 2020 : participation 92 % (22 / 24), presence 92 % (22 / 24) October 2020 : participation 100 % (37 / 37), presence 100 % (37 / 37)

Their votes

215 votes

DateTextResultTheir vote
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MZHG0JG (SYN-ØØØJG-2), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council For
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS-40278-9 and genetically modified maize combining two, three or four of the single events MON 89034, 1507, MON 88017, 59122 and DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the… For
The draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean A2704-12 (ACS-GMØØ5-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Abstention
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet… Absent
Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos… For
Employment and social policies of the euro area For
Foreign electoral interference and disinformation in national and European democratic processes For
Flexibility Instrument: adjustments to the amounts mobilised for 2019 to be used for migration, refugee inflows and security threats Against
Amending budget 4/2019: reduction of commitment and payment appropriations in line with updated needs of expenditure and update of revenue (own resources) For
The importance of European remembrance for the future of Europe For
Iran, notably the situation of women’s rights defenders and imprisoned EU dual nationals For
The state of implementation of the Union’s anti-money laundering legislation For
The state of play of the UK’s withdrawal from the European Union For
Amending budget 2/2019: Horizon 2020 and Erasmus+ For
The situation in Venezuela Absent

Rows per page: 20 40 100 200 All